SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001554795-14-000155
Filing Date
2014-03-07
Accepted
2014-03-07 16:01:02
Documents
10
Period of Report
2014-01-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q gnbt21914form10q.htm 10-Q 571317
2 EXHIBIT 31.1 gnbt21914form10qex31_1.htm EX-31.1 9350
3 EXHIBIT 31.2 gnbt21914form10qex31_2.htm EX-31.2 9318
4 EXHIBIT 32 gnbt21914form10qex32.htm EX-32 4332
  Complete submission text file 0001554795-14-000155.txt   3962676

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE gnbt-20131031.xml EX-101.INS 425770
6 XBRL SCHEMA FILE gnbt-20131031.xsd EX-101.SCH 40175
7 XBRL CALCULATION FILE gnbt-20131031_cal.xml EX-101.CAL 65311
8 XBRL DEFINITION FILE gnbt-20131031_def.xml EX-101.DEF 138472
9 XBRL LABEL FILE gnbt-20131031_lab.xml EX-101.LAB 310404
10 XBRL PRESENTATION FILE gnbt-20131031_pre.xml EX-101.PRE 225814
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANADA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 000-25169 | Film No.: 14677152
SIC: 2834 Pharmaceutical Preparations